Guru Ownership Trend
Guru Analysis for Neurocrine Biosciences, Inc. (NBIX)
Neurocrine Biosciences, Inc. (NBIX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $794.2 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $76.52 M net inflow during the quarter.
Recent activity highlights Ray Dalio who increased their stake by 551.1%. Conversely, Paul Tudor Jones reduced exposure by 27.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Neurocrine Biosciences, Inc. (NBIX)
Major holders include Cliff Asness ($462.65 M), Renaissance Technologies (RenTech) ($317.53 M), Joel Greenblatt ($23.91 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 6.03 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $76.52 M, with 7 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited NBIX. The total reported sell value was $26.5 M.
Yes, 3 managers opened new positions in NBIX, and 4 increased their existing holdings. The total reported buy value was $103.02 M.
